The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Patsatsi, A., Kyriakou A., Vavilis D., Mantas A., Patsialas C., & Sotiriadis D. (2013).  A therapeutic approach for female, relapsing genital lichen sclerosus: a single-center study.. J Dermatolog Treat. 24(5), 336-9.
Patsatsi, A., Pearson D. R., & Werth V. P. (2019).  Dermatomyositis in patients with autoimmune blistering diseases.. Int J Womens Dermatol. 5(4), 256-260.
Patsatsi, A., Kyriakou A., Nasr A., Efstratiou I., & Sotiriadis D. (2014).  Disseminated waxy papules: a sign of systemic disease.. Cutis. 94(1), E3-4.
Patsatsi, A., Kokolios M., Pikou O., Lambropoulos V., Efstratiou I., & Sotiriadis D. (2016).  Sclerotic Regressing Large Congenital Nevus.. Pediatr Dermatol. 33(6), e366-e367.
Patsatsi, A., Kyriakou A., Douma S., Kokolios M., Meltzanidou P., Lambropoulos A., et al. (2019).  Nichtendemischer erythrodermischer Pemphigus foliaceus: Ein Fall mit verzögerter Diagnose und Response auf Rituximab.. J Dtsch Dermatol Ges. 17(5), 537-539.
Patsatsi, A., Vyzantiadis T-A., Chrysomallis F., Devliotou-Panagiotidou D., & Sotiriadis D. (2009).  Medication history of a series of patients with bullous pemphigoid from northern Greece - observations and discussion.. Int J Dermatol. 48(2), 132-5.
Patsatsi, A., Kokolios M., Kyriakou A., Lamprou F., Stylianidou D., Tsapas A., et al. (2017).  Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes. Acta Dermato Venereologica. 97(9), 1145 - 1147.
Patsatsi, A., Kyriakou A., Giannakou A., Pavlitou-Tsiontsi A., Lambropoulos A., & Sotiriadis D. (2014).  Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.. Acta Derm Venereol. 94(2), 203-6.
Patsatsi, A., Kyriakou A., Douma S., Kokolios M., Meltzanidou P., Lambropoulos A., et al. (2019).  Non-endemic erythrodermic pemphigus foliaceus: a case with delayed diagnosis and response to rituximab.. J Dtsch Dermatol Ges. 17(5), 537-539.
Patsatsi, A., Koletsa T., Sotiriadis D., Batsis I., Sakellari I., Anagnostopoulos A., et al. (2015).  Silent T-cell lymphoma of γδ T-cell origin initially presented as panniculitis.. J Eur Acad Dermatol Venereol. 29(6), 1244-5.
Patsatsi, A., Uy C. Dianne C., & Murrell D. F. (2020).  Multiple milia formation in blistering diseases.. Int J Womens Dermatol. 6(3), 199-202.
Patsatsi, A., Kyriakou A., & Sotiriadis D. (2014).  Benign cephalic histiocytosis: case report and review of the literature.. Pediatr Dermatol. 31(5), 547-50.
Patsatsi, A., Kyriakou A., Triantafyllidou E., & Sotiriadis D. (2011).  Interstitial granulomatous dermatitis: another clinical variant.. Case Rep Dermatol. 3(3), 195-200.
Patsas, A., Tsiaousis P., Papaziogas B., Koutelidakis I., Goula C., & Atmatzidis K. (2010).  Repair of a giant inguinoscrotal hernia.. Hernia. 14(3), 305-7.
Patsali, M. E., Mousa D-P. V., Papadopoulou E. V. K., Papadopoulou K. K. K., Kaparounaki C. K., Diakogiannis I., et al. (2020).  University students' changes in mental health status and determinants of behavior during the COVID-19 lockdown in Greece.. Psychiatry Res. 292, 113298.
Patriki, D., & Giannopoulos A. A. (2018).  Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?. J Nucl Cardiol.
Patoulias, D., & Papadopoulos C. (2020).  Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis of Dedicated Renal Outcome Trials Assessing the Cardio-renal Efficacy of Sodium-Glucose Co-transporter-2 Inhibitors in Patients With Chronic Kidney Disease and Albuminuria.
Patoulias, D., & Papadopoulos C. (2020).  Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?.
Patoulias, D., Stavropoulos K., Imprialos K., Katsimardou A., Kalogirou M-S., Koutsampasopoulos K., et al. (2019).  Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs.. Diabetes Res Clin Pract. 158, 107927.
Patoulias, D., & Papadopoulos C. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials.
Patoulias, D., & Papadopoulos C. (2020).  Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.